Both in Biotechnology
Inhibikase Therapeutics vs Palisade Bio
Over the past year IKT returned 0.0% and PALI returned −37.3%; their daily moves had a correlation of 0.15.
IKT 0.0% PALI −37.3%Growth of $1, one year, split-adjusted
| Metric | IKT | PALI |
|---|---|---|
| Price | $1.48 | $1.23 |
| Market cap | $206.5M | $214.4M |
| Today | −3.90% | +9.82% |
| 1 month | −26.0% | −15.8% |
| 6 months | −23.3% | −37.6% |
| Year to date | −27.8% | −47.7% |
| 1 year | +0.7% | −40.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −2114.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 428.7× |
| Net cash | $159.0M | $125.2M |
| Dividend yield | — | — |
| Volatility (60d) | 50.9% | 78.3% |
| Short % of float | 17.8% | 18.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).